BLADDER CANCER Lack of progress in bladder cancer-what are the obstacles?

Research has revealed what we already suspected-randomized controlled trials are lacking in the field of bladder cancer. Many areas require further investigation, and we must try to incentivize clinicians to perform the much-needed trials. A newly established patient advocacy group will be invaluable in this endeavour. Soloway, M. S. Nat. Rev. Urol. 10, 5-6 (2013); published online 20 November 2012; doi:10.1038/nrurol.2012.219